THE INTERSECTION OF BRAIN SCIENCE & HUMAN POTENTIALPartner with us
neurofeedback.com
The newsletter
← Research & Evidence
Positive with limitationsRandomized controlled trial

Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.

Active treatment produced a greater reduction in depression ratings than sham in this small trial. The findings concern a specific intensive, personalized protocol.

Cole EJ, Phillips AL, Bentzley BS, Stimpson KH, Nejad R, Barmak F, Veerapal C, Khan N, Cherian K, Felber E, Brown R, Choi E, King S, Pankow H, Bishop JH, Azeez A, Coetzee J, Rapier R, Odenwald N, Carreon D, Hawkins J, Chang M, Keller J, Raj K, DeBattista C, Jo B, Espil FM, Schatzberg AF, Sudheimer KD, Williams NR.
The American journal of psychiatry · Publication date: 2021-10-29
Added to site: 2026-09-09
DOI: 10.1176/appi.ajp.2021.20101429

Publication date recorded by Europe PMC; online and issue dates may differ.

Modalities
TMS, rTMS
Clinical focus
Depression
Population
Patients with treatment-resistant depression
Sample
32 enrolled; 29 received treatment: 14 active, 15 sham
Intervention / method
Five-day accelerated, high-dose intermittent theta-burst stimulation with individualized MRI targeting
Comparator
Sham stimulation

Clinician summary

At four weeks, mean MADRS reduction was 52.5% with active treatment and 11.1% with sham. This randomized result should not be confused with remission estimates from earlier open-label work.

How to interpret the findings

Small interim trial; longer-term durability and comparisons with other active treatments require further evidence.

Equipment and disclosures

Equipment details were not verified from the reviewed abstract.

Funding and competing-interest disclosures were not verified from the reviewed abstract.

Related evidence

Compare findings from the same clinical area, including mixed results.

Abstract checked · Checked 2026-09-09

Summary prepared with AI assistance. Source verification does not imply an independent replication or a clinician's endorsement. Read our review method.